Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.16
+0.48401.11%
Volume:15.63K
Turnover:689.66K
Market Cap:213.75M
PE:- -
High:44.79
Open:43.99
Low:43.67
Close:43.68
52wk High:47.00
52wk Low:26.62
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.71
T/O Rate:0.32%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
39 mins ago

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

TIPRANKS
·
8 hours ago

NEJM publishes Phase 1/2 clinical data on daraxonrasib

TIPRANKS
·
12 hours ago

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
12 hours ago

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Reuters
·
13 hours ago

Cogent Biosciences - to Purchase Minimum Percentages of Bezuclastinib Products from Hovione - SEC Filing

THOMSON REUTERS
·
13 hours ago

Cogent Biosciences - Agreement Effective for Five-Year Term with Automatic Two-Year Renewals - SEC Filing

THOMSON REUTERS
·
13 hours ago

Cogent Biosciences - Enters Commercial Supply Agreement with Hovione on Sept 1, 2026 - SEC Filing

THOMSON REUTERS
·
13 hours ago

Cogent Biosciences Signs Hovione Supply Deal for Bezuclastinib Tablets

Reuters
·
13 hours ago

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
16 hours ago

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Yesterday

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
Yesterday

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

TIPRANKS
·
Sep 01

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.
·
Sep 01

Eli Lilly (LLY) Eyes Merida Deal As Trial Data Strengthens Autoimmune Push

Simply Wall St.
·
Sep 01

Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...

Dow Jones
·
Sep 01

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Sep 01